INTERNATIONAL PATENT: PROQR THERAPEUTICS II B.V. FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF PEROXISOME BIOGENESIS DISORDERS IN THE ZELLWEGER SPECTRUM (PBD-ZSD)"

GENEVA, May 10 -- PROQR THERAPEUTICS II B.V. (Zernikedreef 92333 CK Leiden) filed a patent application (PCT/EP2025/081179) for "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF PEROXISOME BIOGENESIS DISORDERS IN THE ZELLWEGER SPECTRUM (PBD-ZSD)" on Oct 28, 2025. With publication no. WO/2026/093339, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOYLE, Christopher Kuyler (ProQR Therapeutics ll B.V.Zernikedreef 92333 CK Leiden), HOLKERS, Maarten (ProQR Therapeutics ll B.V.Zernikedreef 92333 CK Leiden), HELFRICHT, Angela (Pr...